Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial—a trial protocol

BACKGROUND: Community-acquired pneumonia (CAP) remains a leading cause of death worldwide, and hypoalbuminemia is associated with worse outcomes. However, it remains uncertain whether albumin administration could have any beneficial effects. We aim to assess whether the administration of albumin in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Trials
Main Authors: Rombauts, Alexander, Abelenda-Alonso, Gabriela, Simonetti, Antonella Francesca, Verdejo, Guillermo, Meije, Yolanda, Ortega, Lucia, Clemente, Mercedes, Niubó, Jordi, Ruiz, Yolanda, Gudiol, Carlota, Tebé, Cristian, Videla, Sebastian, Carratalà, Jordi
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7438978/
https://ncbi.nlm.nih.gov/pubmed/32819439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04627-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares